Research Frontiers Inc 8-K, filed Dec 4, 2020
Research Frontiers Inc (REFR)
About this 8-K
Research Frontiers Inc filed this 8-K on December 4, 2020.
Items reported
- Item 5.02: Director or officer change, or executive pay
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): December 4, 2020
RESEARCH FRONTIERS INCORPORATED
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
| DELAWARE | 000-14893 | 11 -2103466 | ||
| (STATE OR OTHER JURISDICTION | (COMMISSION | (IRS EMPLOYER | ||
| OF INCORPORATION) | FILE NUMBER) | IDENTIFICATION NO.) |
240 CROSSWAYS PARK DRIVE
WOODBURY, NEW YORK 11797-2033
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES AND ZIP CODE)
REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE: (516) 364-1902
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act
| Title of each Class | Trading Symbol(s) | Name of each exchange on which registered | ||
| Common Stock, par value $0.0001 per share | REFR | The NASDAQ Stock Market |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
WOODBURY, NY, December 4, 2020. Research Frontiers Inc. (Nasdaq: REFR) today announced that Seth L. Van Voorhees, Ph.D., Chief Financial Officer and Vice President of Business Development, has resigned his position, effective December 4, 2020, in order to become CFO of a public biotechnology company located in New Jersey.
Joseph M. Harary, President and CEO, who previously served as the company’s Chief Financial Officer, will assume the responsibilities of the position of interim Chief Financial Officer.
“During his nearly ten years at Research Frontiers, Seth has been an important member of our executive team” commented Joseph M. Harary, President and CEO of Research Frontiers. “On behalf of the Board of Directors and the entire Research Frontiers team, we thank Seth for his strategic contribution to Research Frontiers’ growth and mission, and we wish him well in his new endeavor. In addition, we look forward to his continued involvement and input with Research Frontiers as a long-standing shareholder.”
Dr. Van Voorhees added, “I am grateful for my time at Research Frontiers and for the opportunity to work with such an incredible team of leaders. I continue to believe in the strength of Research Frontiers and wish the team all the best and future success.”
Details are noted in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. The Research Frontiers press release is also available on the Company’s website at www.SmartGlass.com and at various other places on the internet.
This report and the press releases referred to herein may include statements that may constitute “forward-looking” statements as referenced in the Private Securities Litigation Reform Act of 1995. Those statements usually contain words such as “believe”, “estimate”, “project”, “intend”, “expect”, or similar expressions. Any forward-looking statements are made by the Company in good faith, pursuant to the safe-harbor provisions of the Act. These forward-looking statements reflect management’s current views and projections regarding economic conditions, industry environments and Company performance. Factors, which could significantly change results, include but are not limited to: sales performance, expense levels, competitive activity, interest rates, changes in the Company’s financial condition and several business factors. Additional information regarding these and other factors may be included in the Company’s quarterly 10-Q and 10K filings and other public documents, copies of which are available from the Company on request. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this report.
The information in this Form 8-K or the press release reproduced herein shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
| 99.1 | Research Frontiers Press Release dated December 4, 2020. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| RESEARCH FRONTIERS INCORPORATED | ||
| /s/ Seth L. Van Voorhees | ||
| By: | Seth L. Van Voorhees | |
| Title: | CFO and VP, Business Development | |
Dated: December 4, 2020
Exhibit 99.1
SETH VAN VOORHEES MOVING TO BIOTECH INDUSTRY
WOODBURY, NY, December 4, 2020. Research Frontiers Inc. (Nasdaq: REFR) today announced that Seth L. Van Voorhees, Ph.D., Chief Financial Officer and Vice President of Business Development, has resigned his position, effective December 4, 2020, in order to become CFO of a public biotechnology company located in New Jersey.
Joseph M. Harary, President and CEO, who previously served as the company’s Chief Financial Officer, will assume the responsibilities of the position of interim Chief Financial Officer.
“During his nearly ten years at Research Frontiers, Seth has been an important member of our executive team” commented Joseph M. Harary, President and CEO of Research Frontiers. “On behalf of the Board of Directors and the entire Research Frontiers team, we thank Seth for his strategic contribution to Research Frontiers’ growth and mission, and we wish him well in his new endeavor. In addition, we look forward to his continued involvement and input with Research Frontiers as a long-standing shareholder.”
Dr. Van Voorhees added, “I am grateful for my time at Research Frontiers and for the opportunity to work with such an incredible team of leaders. I continue to believe in the strength of Research Frontiers and wish the team all the best and future success.”
About Research Frontiers
Research Frontiers (Nasdaq: REFR) is a publicly traded technology company and the developer of patented SPD-Smart light-control film technology which allows users to instantly, precisely and uniformly control the shading of glass or plastic products, either manually or automatically. Research Frontiers has licensed its smart glass technology to over 40 companies that include well known chemical, material science and glass companies. Products using Research Frontiers’ smart glass technology are being used in tens of thousands of cars, aircraft, yachts, trains, homes, offices, museums and other buildings. For more information, please visit our website at www.SmartGlass.com, and on Facebook, Twitter, LinkedIn and YouTube.
Note: From time to time Research Frontiers may issue forward-looking statements which involve risks and uncertainties. This press release contains forward-looking statements. Actual results, especially those reliant on activities by third parties, could differ and are not guaranteed. Any forward-looking statements should be considered accordingly. “SPD-Smart” and “SPD-SmartGlass” are trademarks of Research Frontiers Inc.
CONTACT
Joseph M. Harary
President, Chief Executive Officer
Research Frontiers Inc.
+1-516-364-1902
Info@SmartGlass.com